January 28, 2022
A Healthcare Communications Student Gets an Education as a Patient
Read More
January 28, 2022
Oxford Biomedica Buys Homology’s In-House AAV Manufacturing Business
Read More
January 28, 2022
Amryt Faces Delay in Approval of EB Therapy in Europe
Read More
January 27, 2022
Rare Leader: Amy Wood, Executive Director, Raymond A. Wood Foundation
Read More
January 27, 2022
Sierra Oncology Raises $135 Million in Public Offering to Support Late Stage Rare Cancer Pipeline
Read More
January 27, 2022
Epizyme Raises $85 Million through Public Offering
Read More
January 27, 2022
Alexion Donates $1 Million to n-Lorem to Develop and Provide Free Individualized Medicines to Nano-rare Patients
Read More
January 26, 2022
FDA Approves Immunocore’s Kimmtrak to Treat Unresectable or Metastatic Uveal Melanoma
Read More
January 26, 2022
FDA Places Hold on Mustang Bio’s XSCID Gene Therapy
Read More
January 26, 2022
Cancer Drug Shows Promise in Rare Disease
Read More
January 25, 2022
Finding Answers Through Genetic Testing – A Personal Journey
Read More
January 25, 2022
Metagenomi Raises $175 Million to Advance Therapeutic Pipeline and Expand Gene Editing Platform
Read More
Load More
X